Your browser doesn't support javascript.
loading
Comparison of COVID-19 vaccine policies and their effectiveness in Korea, Japan, and Singapore.
Ma, Mengyuan; Shi, Leiyu; Liu, Meiheng; Yang, Junyan; Xie, Wanzhen; Sun, Gang.
Afiliação
  • Ma M; Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, 510515, China.
  • Shi L; Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
  • Liu M; Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, 510515, China.
  • Yang J; Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, 510515, China.
  • Xie W; Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, 510515, China.
  • Sun G; Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, 510515, China. sunhoney163@163.com.
Int J Equity Health ; 22(1): 224, 2023 10 20.
Article em En | MEDLINE | ID: mdl-37864164
ABSTRACT

BACKGROUND:

This study aimed to analyze coronavirus disease 2019 (COVID-19)vaccine policies and effectiveness in Korea, Japan, and Singapore, thereby providing empirical experience for vaccination and response to similar public health emergencies.

METHODS:

The study systematically summarized the COVID-19 vaccine policies in Korea, Japan, and Singapore through public information from the Our World in Data website and the official websites of the Ministries of Health in these three countries.Total vaccinations, COVID-19 vaccination rates, rates of fully vaccinated, rates of boostervaccinated, and total confifirmed cases were selected for cross-sectional comparison of COVID-19 vaccination in these three countries. Combining the basic characteristics of these three countries, daily cases per million, daily deaths per million, and the effective reproduction rate were calculated to measure the effectiveness of COVID-19 vaccine policies implementation in each of these three countries

RESULTS:

The countermeasures against the COVID-19 in Korea, Japan, and Singapore, although seemingly different on the surface, have all taken an aggressive approach. There are large similarities in the timing of the start of COVID-19 vaccination, the type of vaccine, how vaccine appointments are made, and whether vaccination are free, and all had high vaccination rates. A systematic comparison of the anti-epidemic practices in the three East Asian countries revealed that all three countries experienced more than one outbreak spike due to the spread of new mutant strains after the start of mass vaccination with COVID-19 vaccination, but that vaccination played a positive role in reducing the number of deaths and stabilizing the effective reproduction rate.

CONCLUSIONS:

This study comparatively analyzed the COVID-19 vaccine policies and their effects in South Korea, Japan, and Singapore, and found that there is a common set of logical combinations behind the seemingly different strategies of these three countries. Therefore, in the process of combating COVID-19, countries can learn from the successful experience of combating the epidemic and continue to strengthen the implementation of vaccination programs, as well as adjusting public perceptions to reduce the level of vaccine hesitancy, enhance the motivation for vaccination, and improve the coverage of COVID-19 vaccine based on different cultural factors, which remains the direction for future development.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Equity Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Equity Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China